BTG PLC (BTG.L)

BTG.L on London Stock Exchange

640.50GBp
29 Aug 2014
Price Change (% chg)

-4.50p (-0.70%)
Prev Close
645.00p
Open
643.00p
Day's High
650.50p
Day's Low
636.50p
Volume
318,089
Avg. Vol
471,595
52-wk High
667.00p
52-wk Low
363.00p

BTG.L

Chart for BTG.L

About

BTG plc is an international specialist healthcare company. The Company is focused on three business areas: Specialty Pharmaceuticals, Interventional Medicine and Licensing & Biotechnology. Its focus within Specialty Pharmaceuticals is on antidote products that are used within hospitals. Its interventional medicine products are... (more)

Overall

Beta: 0.31
Market Cap (Mil.): £2,322.68
Shares Outstanding (Mil.): 362.64
Dividend: --
Yield (%): --

Financials

  BTG.L Industry Sector
P/E (TTM): 93.39 32.64 33.56
EPS (TTM): 0.07 -- --
ROI: 4.41 18.00 17.31
ROE: 5.04 18.64 18.05
Search Stocks

BRIEF-BTG receives FDA nod for pulmonary embolism treatment

* Ekosonic endovascular system receives FDA clearance for treatment of pulmonary embolism in USA Source text for Eikon: Further company coverage:

23 May 2014

BRIEF-BTG full-year pretax profit rises 38 pct

* FY pretax profit 33.3 million stg versus 24.1 million stg year ago

20 May 2014

BRIEF-BTG sees year revenue around top end of guidance range

LONDON, April 3 - BTG plc update for the year ended 31 March 2014:

03 Apr 2014

Earnings vs. Estimates

Search Stocks